Search Results

Filter
  • 1-10 of  36 results for ""GLUCAGON-like peptides""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

[New outcome studies with injectable semaglutide in different at risk populations].

  • Authors : Scheen A; Service de Diabétologie, Nutrition et Maladies métaboliques et Unité de Pharmacologie clinique, CHU Liège, ULiège, Belgique.; Delanaye P

Subjects: Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Revue medicale de Liege [Rev Med Liege] 2024 Oct; Vol. 79 (10), pp. 676-682.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

×
Academic Journal

La metformine comme stabilisateur de poids après l’arrêt du sémaglutide ?

  • Authors : Da Graça S; Service de médecine de premier recours, Hôpitaux universitaires de Genève.

Subjects: Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use ; Metformin*/Metformin*/Metformin*/administration & dosage

  • Source: Revue medicale suisse [Rev Med Suisse] 2024 Jul 17; Vol. 20 (882), pp. 1380.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Editorial & Opinion

[Among adults with cardiovascular disease and BMI≥27kg/m 2 but no diabetes, does semaglutide lower risk of cardiovascular mortality, myocardial infarction, or stroke when compared with placebo, and is it safe?]

  • Authors : Lanthier L; Département de médecine spécialisé, service de médecine interne générale, université de Sherbrooke, Sherbrooke, QC, Canada. Electronic address: .; Langlois MF

Subjects: Cardiovascular Diseases* ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/epidemiology ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/drug therapy

  • Source: La Revue de medecine interne [Rev Med Interne] 2024 Mar; Vol. 45 (3), pp. 178-179. Date of Electronic Publication: 2024 Jan 16.Publisher: Elsevier Country of Publication: France NLM ID: 8101383 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3122

Record details

×
Periodical

Adultes en surpoids ou obèses : effets du sémaglutide.

  • Authors : Bernard S; Service de médecine de premier recours, HUG, Genève.

Subjects: Glucagon-Like Peptides* ; Overweight*; Adult

  • Source: Revue medicale suisse [Rev Med Suisse] 2021 Jun 16; Vol. 17 (743), pp. 1186.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

[An orally administered glucagon-like peptide 1 (GLP1) analogue: A landmark in the treatment of type 2 diabetes].

  • Authors : Larger É; Université de Paris et Service de diabétologie et immunologie clinique, Hôpital Cochin, APHP centre-université de Paris, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*analogs & derivatives ; Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*administration & dosage

  • Source: Medecine sciences : M/S [Med Sci (Paris)] 2021 Jan; Vol. 37 (1), pp. 53-58. Date of Electronic Publication: 2021 Jan 25.Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1958-5381

Record details

×
Academic Journal

[Semaglutide, once weekly GLP-1 receptor agonist (Ozempic®)].

  • Authors : Scheen AJ; Service de Diabétologie, Nutrition et Maladies métaboliques et Unité de Pharmacologie clinique, CHU Liège.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: Revue medicale de Liege [Rev Med Liege] 2019 Sep; Vol. 74 (9), pp. 488-494.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

×
Academic Journal

[Oxyntomodulin, a new hormonal marker of intestinal malabsorption syndromes].

Subjects: Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*blood ; Malabsorption Syndromes/Malabsorption Syndromes/Malabsorption Syndromes/*blood; Adult

  • Source: La Revue de medecine interne [Rev Med Interne] 1993; Vol. 14 (10), pp. 982.Publisher: Elsevier Country of Publication: France NLM ID: 8101383 Publication Model: Print Cited Medium: Print ISSN: 0248-8663 (Print)

Record details

×
Academic Journal

[Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands].

Subjects: Gastrointestinal Hormones/Gastrointestinal Hormones/Gastrointestinal Hormones/*physiology ; Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*physiology ; Parietal Cells, Gastric/Parietal Cells, Gastric/Parietal Cells, Gastric/*physiology

  • Source: Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie [C R Acad Sci III] 1984; Vol. 299 (16), pp. 677-80.Publisher: Éditions Scientifiques et Médicales Elsevier Country of Publication: France NLM ID: 8503078 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

[Bioactive "enteroglucagon" (oxyntomodulin): evidence for a C-terminal extension of the glucagon molecule].

Subjects: Gastrointestinal Hormones/Gastrointestinal Hormones/Gastrointestinal Hormones/*analysis ; Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*analysis; Amino Acid Sequence

  • Source: Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie [C R Seances Acad Sci III] 1981 Oct 19; Vol. 293 (6), pp. 323-8.Publisher: Gauthier Villars Country of Publication: France NLM ID: 8108553 Publication Model: Print Cited Medium: Print ISSN: 0249-6313 (Print)

Record details

×
  • 1-10 of  36 results for ""GLUCAGON-like peptides""